Table: SymBio Pharmaceuticals -Q1 group results

SymBio Pharmaceuticals

08/05/2025 07:34

May 8 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2025        Mar 31, 2024      Dec 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            264 mln             597 mln            1.86      
                 (-55.8 pct)         (-61.3 pct)       (-24.3 pct)  
  Operating       loss 1.17         loss 806 mln        loss 4.26   
  Recurring       loss 1.29         loss 727 mln        loss 4.35   
  Net             loss 1.32         loss 777 mln        loss 4.47   
  EPS          loss 27.95 yen      loss 18.03 yen    loss 80.45 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T